Tender Title:

702 MS ECHS BOQ GEM MEDICINE RE 05 IFA 2025 26
Reference Number: GEM/2025/B/6150723

Issuing Authority/Department:

Department of Military Affairs, Ministry of Defence

Scope of Work and Objectives:

The primary objective of this tender is to procure a wide range of pharmaceuticals, including but not limited to Chlorthalidone 6.25 MG Tablets, Chlorzoxazone 500 MG, Diclofenac 50 MG, Paracetamol 325 MG Tablets, and Cholecalciferol 60000 IU Sachets. This includes a total quantity of 175,738 items, delineated in the provided Bill of Quantities (BOQ). The tender aims to ensure that the Medical Services of the Indian Armed Forces have reliable access to essential medicines for the health and well-being of service personnel and their families.

Eligibility Criteria:

Bidders must meet the following eligibility requirements:

• Registration as a pharmaceutical supplier or manufacturer.
• Proven experience in the supply of medicinal products to government agencies or private sectors.
• Compliance with all applicable regulations and standards governing pharmaceutical products within India.

Technical Requirements:

Bidders are required to supply the listed medications as per the prescribed specifications in the BOQ. All medicines must conform to recognized quality and safety standards, including but not limited to:

• Certification from relevant health authorities.
• Quality Assurance documentation and compliance with Good Manufacturing Practices (GMP).

Financial Requirements:

Financial stability is crucial for participation in this tender. Bidders must demonstrate their financial health through:

• Submission of recent financial statements.
• Evidence of capability to fulfill the order quantity specified in the BOQ.

Document Submission Details:

Bidders must prepare and submit the following documents:

• Completed tender application form.
• Proof of eligibility, including registration certificates.
• Quality compliance certificates.
• Financial documents.

All documents should be submitted electronically through the designated procurement portal, ensuring compliance with format guidelines stipulated in the tender documentation.

Special Provisions:

This tender may include benefits for Micro, Small, and Medium Enterprises (MSEs) and startups, as stipulated by the government policies aimed at promoting domestic suppliers and new vendors in the pharmaceutical sector.

Evaluation Process:

The evaluation will be based on:

• Compliance with technical specifications.
• Complete and accurate documentation.
• Financial viability.
• Price evaluation, which will factor in overall cost, quality, and delivery timelines.

Delivery Locations:

The delivery locations would primarily include military hospitals, health centers, and other designated facilities under the jurisdiction of the Department of Military Affairs.

Contact Information:

For further queries and clarifications, bidders are advised to refer to the official contact details provided in the tender documentation.

This tender represents a significant opportunity for suppliers in the pharmaceutical industry to engage with government health services. Bidders are encouraged to thoroughly review all requirements carefully and submit proposals that reflect a clear understanding of the objectives and specifications outlined herein.

---